January 20, 2017
MSD divests 6 brands to Zydus Healthcare Limited
United States pharmaceutical giant Merck & Co., Inc. (known as Merck Sharp & Dohme (MSD) outside the United States and Canada), through its subsidiaries, divested its 6 brands to Zydus Cadila’s wholly owned subsidiary Zydus Healthcare Limited. Pharmaceutical products in the segment of men’s and women’s health, wound management and cardiovascular therapy were sold under these brands.
In addition to the sale of brand names, Organon India Private Limited, an Indian subsidiary company of Merck & Co., Inc. /MSD, assigned manufacturing know-how, distribution and commercialization rights for 3 of the brands sold as part of the deal.
We, at Nishith Desai Associates, acted as the Indian legal and regulatory counsel to MSD.